MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
450.37M
P/E Ratio
N/A
Total Cash
132.89M
Projected Growth
N/A
Total Debt
8.91M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LXEO
Capitalization
450M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
133M
Total Cash/Share
2.46
Total Debt
8.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
138M
P/B Ratio
3.26
Cash Flow
N/A
Earnings
-3.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
4.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-111.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.04
Shares Held By Institutions
184M
Shares Outstanding - Current
54M
Total Liabilities
37.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-1.672
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXEO showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com